抄録
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique to acquire both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the staging, optimization of treatment, re-staging, therapy monitoring, and prognostic prediction of uterine cervical cancer and endometrial cancer as well as various malignant tumours. The present review discusses the current role of FDG-PET/CT in the management of uterine cancer, discussing its usefulness and limitations in the imaging of these patients.
| 本文言語 | English |
|---|---|
| ページ（範囲） | 297-307 |
| ページ数 | 11 |
| ジャーナル | Clinical Radiology |
| 巻 | 66 |
| 号 | 4 |
| DOI | |
| 出版ステータス | Published - 2011 4月 |
ASJC Scopus subject areas
- 放射線学、核医学およびイメージング
UN SDG
この成果は、次の持続可能な開発目標に貢献しています
